SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025261
Filing Date
2019-05-10
Accepted
2019-05-10 16:03:57
Documents
110
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520144_10q.htm 10-Q 1026499
2 EXHIBIT 10.1 tv520144_ex10-1.htm EX-10.1 584164
3 EXHIBIT 31.1 tv520144_ex31-1.htm EX-31.1 10682
4 EXHIBIT 31.2 tv520144_ex31-2.htm EX-31.2 10406
5 EXHIBIT 32.1 tv520144_ex32-1.htm EX-32.1 4047
6 EXHIBIT 32.2 tv520144_ex32-2.htm EX-32.2 4042
  Complete submission text file 0001144204-19-025261.txt   15873996

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20190331_cal.xml EX-101.CAL 91184
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20190331_def.xml EX-101.DEF 665812
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20190331_lab.xml EX-101.LAB 668497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20190331_pre.xml EX-101.PRE 723484
11 XBRL INSTANCE DOCUMENT fbio-20190331.xml EX-101.INS 5248449
12 XBRL TAXONOMY EXTENSION SCHEMA fbio-20190331.xsd EX-101.SCH 107560
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 19814826
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences